Terms: = Uterine cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Prognosis
136 results:
1. A comprehensive analysis and experimental validation of TK1 in uterine corpus endometrial carcinoma.
Sun Y; Zhang K; Wang T; Zhao S; Gao C; Xue F; Wang Y
Sci Rep; 2024 Mar; 14(1):6134. PubMed ID: 38480789
[TBL] [Abstract] [Full Text] [Related]
2. Mitofusin-2 enhances cervical cancer progression through Wnt/β-catenin signaling.
Ahn SY
BMB Rep; 2024 Apr; 57(4):194-199. PubMed ID: 38449303
[TBL] [Abstract] [Full Text] [Related]
3. HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
Zhang J; Yu X; Guo Y; Wang D
Cancer Med; 2024 Feb; 13(3):e6875. PubMed ID: 38205938
[TBL] [Abstract] [Full Text] [Related]
4. Exploring the significance of tumor volume in endometrial cancer: Clinical pathological features, prognosis, and adjuvant therapies.
Fan Z; Sun X; Han X; Sun C; Huang D
Medicine (Baltimore); 2023 Dec; 102(50):e36442. PubMed ID: 38115321
[TBL] [Abstract] [Full Text] [Related]
5. SNHG3/WISP2 Axis Promotes Hela Cell Migration and Invasion
Xu D; Feng H; Ren Z; Li X; Jiang C; Chen Y; Liu L; Chen W; Cui Z; Cang S
Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):744-753. PubMed ID: 38035707
[TBL] [Abstract] [Full Text] [Related]
6. USP14 predicts poorer survival outcomes and promotes tumor progression in endometrial carcinoma by activating NF-κB signaling.
Gong X; Jia L; Zhou L; Hu T
Aging (Albany NY); 2023 Nov; 15(21):12120-12135. PubMed ID: 37917013
[TBL] [Abstract] [Full Text] [Related]
7. Histone acetyltransferase CSRP2BP promotes the epithelial-mesenchymal transition and metastasis of cervical cancer cells by activating N-cadherin.
Yang X; Sun F; Gao Y; Li M; Liu M; Wei Y; Jie Q; Wang Y; Mei J; Mei J; Ma L; Shi Y; Chen M; Li Y; Li Q; Liu M; Ma Y
J Exp Clin Cancer Res; 2023 Oct; 42(1):268. PubMed ID: 37845756
[TBL] [Abstract] [Full Text] [Related]
8. UBE2C serves as a prognosis biomarker of uterine corpus endometrial carcinoma via promoting tumor migration and invasion.
Ma S; Chen Q; Li X; Fu J; Zhao L
Sci Rep; 2023 Oct; 13(1):16899. PubMed ID: 37803076
[TBL] [Abstract] [Full Text] [Related]
9. Pathogenomics model for personalized medicine in cervical cancer: Cross-talk of gene expressions and pathological images related to oxidative stress.
Li J; Chen S; Wu J; Liu X; Liu H; Liu Y; Zhu Z
Environ Toxicol; 2024 Feb; 39(2):751-767. PubMed ID: 37755325
[TBL] [Abstract] [Full Text] [Related]
10. An emt-related genes signature as a prognostic biomarker for patients with endometrial cancer.
Yu Y; Zhang Y; Li Z; Dong Y; Huang H; Yang B; Zhao E; Chen Y; Yang L; Lu J; Qiu F
BMC Cancer; 2023 Sep; 23(1):879. PubMed ID: 37723477
[TBL] [Abstract] [Full Text] [Related]
11. The promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer.
Zhang M; Hong X; Ma N; Wei Z; Ci X; Zhang S
J Transl Med; 2023 Jul; 21(1):433. PubMed ID: 37403143
[TBL] [Abstract] [Full Text] [Related]
12. LINC00426, a novel m
Shen S; Jin H; Zhang X; Zhang Y; Li X; Yan W; Xie S; Yu B; Hu J; Liu H; Chen X; Nie Y; Liu F; Tang M; Gu Y; Wang S
Cell Signal; 2023 Sep; 109():110788. PubMed ID: 37392859
[TBL] [Abstract] [Full Text] [Related]
13. A novel epithelial-mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer.
Jin Y; Qiu Y; Li Y; Jiang Z; Hu S; Dai H
Medicine (Baltimore); 2023 Jun; 102(26):e34126. PubMed ID: 37390286
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of the characteristics of immune infiltration in endometrial carcinoma and its relationship with prognosis based on bioinformatics.
Lin Y; Liu S; Lin C; Lin P; Teng Z; Zhu G
Medicine (Baltimore); 2023 Jun; 102(25):e34156. PubMed ID: 37352032
[TBL] [Abstract] [Full Text] [Related]
15. Role of non‑coding RNA intertwined with the Wnt/β‑catenin signaling pathway in endometrial cancer (Review).
Tian Y; Lai T; Li Z; Mao M; Jin Y; Liu Y; Guo R
Mol Med Rep; 2023 Aug; 28(2):. PubMed ID: 37350380
[TBL] [Abstract] [Full Text] [Related]
16. TGF-β signaling promotes cervical cancer metastasis via CDR1as.
Zhong G; Zhao Q; Chen Z; Yao T
Mol Cancer; 2023 Mar; 22(1):66. PubMed ID: 37004067
[TBL] [Abstract] [Full Text] [Related]
17. Effects of Fractionated Radiation Exposure on Vimentin Expression in Cervical cancers: Analysis of Association with cancer Stem Cell Response and Short-Term prognosis.
Zamulaeva I; Matchuk O; Selivanova E; Mkrtchian L; Yakimova A; Gusarova V; Lipunov N; Krikunova L; Ivanov S; Kaprin A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834676
[TBL] [Abstract] [Full Text] [Related]
18. Expression of emt-related genes in lymph node metastasis in endometrial cancer: a TCGA-based study.
Li H; Wang J; Li L; Zhao L; Wang Z
World J Surg Oncol; 2023 Feb; 21(1):55. PubMed ID: 36814242
[TBL] [Abstract] [Full Text] [Related]
19. Comprehensive analysis of PHGDH for predicting prognosis and immunotherapy response in patients with endometrial carcinoma.
Zhang H; Kong W; Zhao X; Xie Y; Luo D; Chen S
BMC Med Genomics; 2023 Feb; 16(1):29. PubMed ID: 36803157
[TBL] [Abstract] [Full Text] [Related]
20. LMCD1-AS1 Facilitates Cell Proliferation and emt by Sponging miR-873-3p in Cervical cancer.
Liang M; Li Y; Chen C
Crit Rev Eukaryot Gene Expr; 2023; 33(2):13-25. PubMed ID: 36734854
[TBL] [Abstract] [Full Text] [Related]
[Next]
